Client Results & Business Cases

EFESO conducted a feasibility study for a new 10,000-pallet automated warehouse in Romania, optimizing logistics design, layout, and CAPEX to enable scalable, efficient pharmaceutical distribution.

EFESO supported a major cosmetics supplier in redesigning operations across six factories and optimizing the supply chain, targeting improved productivity and long-term profitability.

A mid-sized pharmaceutical company achieved measurable efficiency, cost, and delivery improvements at four European sites through EFESO’s Operational Excellence and Digital Transformation programs.

A QC lab optimization framework helps a multinational chemical-pharmaceutical company achieved simultaneous gains in productivity, service level, and resource efficiency, delivering measurable improvements in release time, productivity, and FTE requirements without compromising quality.

Reengineered Order Management processes for pharma services provider, achieving 30% OTIF improvement to 95% target.

Transformed manual Excel-based supply planning into automated digital tool, delivering 90% reduction in manual effort.

Integrated two pharmaceutical companies across five countries, delivering 15% operational cost synergies and 13% revenue growth.

Designed customized Maturity Assessment System for global pharma network. Trained 30 internal assessors, enabling site-wide collaboration.

Identified production constraints across API manufacturing processes, enabling capacity expansion that delivered EUR 2.6m benefit.

Redesigned operational excellence across 23 plants, unifying fragmented practices and internalizing production for global consumer health company.

Pharmaceutical manufacturer reduces production costs 30-40% while preparing operations for 2027 capacity expansion and growth.

Pharmaceutical manufacturer optimized three-factory footprint, postponing €300M investment while achieving 20% growth through strategic operations transformation.

Streamlined biotechnology contract manufacturing operations, reducing 18-24 month lead times by 60% and inventory by 45%.

Developed comprehensive five-year business plan for European CRO, identifying 40% growth potential through strategic positioning.

Aligned pharmaceutical manufacturing footprint with 2030 growth targets, delivering €100M savings and 15% CapEx reduction.

Healthcare giant required operational transformation in consumer products division. We implemented continuous improvement, automated key processes, and enhanced quality systems, delivering 20% productivity gain.

Stabilized pharma production through tailored training and servant leadership, delivering €5M+ savings across 20 lines.

Assessed three pharma plants, prioritized 50 Smart Factory initiatives, achieving 1.4-year payback on first wave.

Biologics manufacturer stabilizes supply through standardized QC lab operations, achieving 15% productivity improvement across global sites.